Carcinoembryonic Antigen (CEA) Market : Worldwide Study on Top Players | F. Hoffmann-La Roche Ltd., Quest Diagnostics, GenWay Biotech Inc., Correlogic Systems, Inc., Creative Diagnostics, Omega Diagnostics Group PLC, RayBiotech, Inc., and Boster Biologica
Japan dominated the Asian market and was valued around USD 74.6 million in the year 2017. Growing awareness about pre-disease diagnosis and prevention will further drive the market growth. Additionally, rising per capita healthcare expenditure and growing demand for rapid and cost effective carcinoembryonic antigen tests will fuel the market growth in Japan.
Some of the leading players in the carcinoembryonic antigen market include F. Hoffmann-La Roche Ltd., Quest Diagnostics, GenWay Biotech Inc., Correlogic Systems, Inc., Creative Diagnostics, Omega Diagnostics Group PLC, RayBiotech, Inc., and Boster Biological Technology. These companies opt for strategic decisions such as mergers, acquisitions, and partnerships in order to increase their efficiency and sustain in the market.
Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/427
Gastrointestinal cancer market was valued around USD 652.4 million in the year 2017. According to an article published in the National Center for Biotechnology Information, gastrointestinal cancer is the fourth most common malignancy worldwide and remains the second most common cause of death of all malignancies globally, hence driving the market growth for carcinoembryonic antigen.
Breast cancer market is estimated to grow at a CAGR of 7.3% over the projection period. Breast cancer is the most common cancer affecting the women population. Furthermore, breast cancer diagnosis involves three tumor markers, one of them being carcinoembryonic antigen; carcinoembryonic antigen tests have been used to help monitor metastatic breast cancer (advanced disease), that will propel the industry growth in the forthcoming years.
Males in carcinoembryonic antigen market was valued around USD 1,003.2 million in the year 2017. The rationale for greater market share in men carcinoembryonic antigen market is the greater frequency of cancer diagnosis, rather than poorer survival once the cancer is diagnosed at a late stage. Furthermore, lifestyle-related factors such as smoking, drinking increasing amounts of alcohol, putting on weight, and taking less exercise are also responsible for the largest share of males in carcinoembryonic antigen market.
Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/427
The hospitals market is projected to grow at a considerable CAGR of 6.1% over the forecast timeframe owing to increasing number of hospital admissions. Geriatric population suffering from cancers requiring continuous monitoring prefer minimally invasive procedures carried out in hospitals and clinics, that will boost the market growth.
Carcinoembryonic Antigen Market size is set to reach USD 3.0 billion by 2024; according to a new research study published by Global Market Insights, Inc. Constant advancement in technology such as proteomics that includes mass spectrometry, protein bioinformatics, protein labelling, imaging and array-based approaches with the development of new biomarkers that can be used in combination with other biomarkers is anticipated to fuel the demand for carcinoembryonic antigen market growth during the forecast timeframe. Favorable government initiatives for the improvement of diagnostic rates and the advancement of new combination biomarkers has immense growth opportunities for carcinoembryonic antigen market. Hence, it will result in increasing demand for effective carcinoembryonic antigen tests, thereby fueling business growth.
Rising geriatric population base coupled with growing number of cancer diseases is driving the carcinoembryonic antigen market size over the forecast timeframe. According to the World Health Organization, cancer is the second leading cause of death globally, with an estimated 9.6 million deaths in 2018. Additionally, worldwide, about 1 in 6 deaths is due to cancer. All these factors will propel the global market growth.
The inability of carcinoembryonic antigen tests to detect early stage cancer will be a major market impeding factor. In addition, lack of awareness regarding the application of carcinoembryonic antigen tests will decrease the demand, thus hindering the market growth.
Carcinoembryonic antigen market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2013 to 2024, for the following segments:
Carcinoembryonic antigen (CEA) market by Application
• Gastrointestinal Cancer
o Colon Cancer
o Pancreatic Cancer
o Rectal Cancer
o Liver Cancer
o Stomach Cancer
o Esophageal Cancer
o Gallbladder Cancer
o Anal Cancer
• Breast Cancer
• Lung Cancer
• Ovarian Cancer
• Prostate Cancer
• Thyroid Cancer
Carcinoembryonic antigen (CEA) market by Gender
Carcinoembryonic antigen (CEA) market by End-user
• Diagnostic Centers
• Cancer Centers
• Research and Academic Institutes
The above information is provided for the following regions/countries:
• North America
• Asia Pacific
o South Korea
o New Zealand
• Latin America
• Middle East and Africa
o South Africa
o Saudi Arabia
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Corporate Sales, USA
Global Market Insights, Inc.
Toll Free: 1-888-689-0688
Blog : http://news-researchers.com/
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Carcinoembryonic Antigen (CEA) Market : Worldwide Study on Top Players | F. Hoffmann-La Roche Ltd., Quest Diagnostics, GenWay Biotech Inc., Correlogic Systems, Inc., Creative Diagnostics, Omega Diagnostics Group PLC, RayBiotech, Inc., and Boster Biologica here
News-ID: 1636258 • Views: 626
More Releases from Global Market Insights, Inc.
Hypochlorite Bleaches Market to hit US$ 300 Mn 2025 | Top Key Players like Adity …
As per the research report by Global Market Insights, Inc., Global Hypochlorite Bleaches Market to cross USD 300 million by 2025 and grow at 3.4% CAGR from 2019 to 2025. It has been projected that the Global hypochlorite bleaches market is expected to reach a consumption of around 485-kilo tons by 2025. Water scarcity as well as rising water costs have led to more emphasis being laid on water recycling and
Feminine Hygiene Products Market: Growing awareness regarding intimate health in …
Global Market Insights, Inc., announces an ongoing comprehensive report on the Feminine Hygiene Products Market. One of the most hushed topics across the world is female hygiene, the negligence of which results in several diseases. Studies claim that nearly 30% to 60 % women across the globe develop urinary tract infection once in their lifetime, mainly due to negligence in proper intimate hygiene. Dearth of knowledge regarding the negative consequences of
Examination Gowns Market 2020 business trends & growth opportunities to 2026
Global Market Insights, Inc., announces an ongoing comprehensive report on the Examination Gowns Market. The exposure to various kinds of hospital acquired infections has led to a spate of health problems for the healthcare professionals as well has the patients. In this regard, experts have been massively shifting to adoption of personal protective equipment or clothing, examination gowns, protecting them from all kinds of infections. These gowns are present in the
Nonwoven Packaging Market to witness increased demand from pharmaceutical sector …
Global Market Insights, Inc., announces an ongoing comprehensive report on the Nonwoven Packaging Market. With the world struggling to fight against negative consequences of industrialization and increased carbon emissions, nonwovens or nonwoven fabrics have emerged as an intrinsic solution for all ecological imbalances across the globe. These fabrics are made from staple fiber and long fibers, merged together by chemical, heat, or mechanical treatment. These are generally used in textile manufacturing
More Releases for Cancer
Cancer Vaccines Market
Manufacturers in the cancer vaccines market are focusing on developing new vaccines in order to treat various cancers. Through this, they are expected to gain a competitive edge in the market and increase their market share. For instance, Gilead Science Inc., in 2017, acquired Kite Pharma Inc., which is involved in development of different type of immunotherapy and vaccines. Also, Treos Bio, in 2017, collaborated with Pharmaceutical Product Development, LLC
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Molecular Biomarkers Market
Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body. A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluids. Cancer molecular biomarkers help to diagnose cancer and monitor patients’ responses to treatments. On the basis of diagnostics, the cancer molecular
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global Cancer Vaccines Market 2016: Liver cancer, Cervical cancer, Stomach cance …
Latest industry research report on Cancer vaccines are the type of immunotherapy (also named as biologic therapy), designed to boost body's natural defense against cancer. The body's natural immune system recognizes vaccine proteins as the foreign particles and sets up an immunity against them. According to World Health Organization (WHO), cancer is a leading cause of worldwide mortality registering ~14 million new cases and ~8.2 million cancer-related diseases in 2012. Personalized
Taking thyroid cancer seriously
With the increasing incidence rate of thyroid cancer in Metro Cebu, the Eduardo J. Aboitiz Cancer Center (EJACC) of the Ramon Aboitiz Foundation Inc. (RAFI) urged the public to undergo early screening and prevention measures to fight the disease. “Thyroid cancer is high on prognosis. It is preventable through various screening methods, such as physical examination and ultrasound of the neck, as well as some prevention measures, including regular exercise and